Top

International Journal of Colorectal Disease

Published in:

Open Access 01-11-2017 | Original Article

The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment

Authors: M. J. Wilson, J. W. T. Dekker, J. J. Harlaar, J. Jeekel, M. Schipperus, J. J. Zwaginga

Published in: International Journal of Colorectal Disease | Issue 11/2017

Abstract

Background

In preoperative blood management of colorectal cancer patients, intravenous iron therapy is increasingly used to treat anaemia and prevent red blood cell transfusions. However, while iron deficiency is the most common cause of anaemia, little is known about the prevalence and namely type of iron deficiency in this population, whereas both types of iron deficiency (i.e. absolute and functional iron deficiency) are recommended to be treated differently by international cancer guidelines.

Objective

The aim of present study is to investigate the prevalence and namely type of iron deficiency in colorectal cancer patients, and to assess its clinical relevance.

Methods

Preoperative iron status, clinical parameters (i.e. age, ASA classification, tumour location, tumour stage) and postoperative complications were retrospectively collected for all newly diagnosed colorectal cancer patients in our institution over a 3-year period.

Results

Iron deficiency was observed in 163 (48.1%) of 339 patients. Of these iron-deficient patients, 3.7% had an isolated absolute iron deficiency (AID) and 15.3% a functional iron deficiency (FID), while the rest had a combination of AID and FID. Anaemia was present in 66.1% of iron-deficient patients. Iron deficiency was significantly associated with an increased postoperative complication rate (univariable OR 1.94, p = 0.03, multivariable OR 1.84, p = 0.07), with right-sided tumours (p < 0.001), high ASA classification (p = 0.002), advanced tumour stage (p = 0.01) and advanced age (p = 0.04). In comparing clinical parameters between patients with AID and FID, advanced age was significantly associated with FID (p = 0.03), and the presence of anaemia with AID (p = 0.02).

Conclusion

In preoperative colorectal cancer patients, there is a high prevalence of iron deficiency, including a high percentage of patients with—a component of—functional iron deficiency, associated with the increased postoperative complication rate. As both types of iron deficiency require a different treatment strategy, our results illustrate the therapeutic potential of especially intravenous iron supplementation in patients with severe iron deficiency and stress the urgency of routinely monitoring preoperative iron status and differentiation between types of iron deficiency. As iron therapy may also be potentially harmful in respect to stimulation of tumour growth, future clinical trials assessing the long-term effect of iron therapy are necessary.

Bastide NM, Chenni F, Audebert M, Santarelli RL, Tache S, Naud N, Baradat M, Jouanin I, Surya R, Hobbs DA, Kuhnle GG, Raymond-Letron I, Gueraud F, Corpet DE, Pierre FH (2015) A central role for heme iron in colon carcinogenesis associated with red meat intake. Cancer Res 75(5):870–879CrossRefPubMed

Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM (2015) Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 102(11):1314–1324CrossRefPubMed

van Halteren HK, Houterman S, Verheij CD, Lemmens VE, Coebergh JW (2004) Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. Eur J Surg Oncol 30(6):628–632CrossRefPubMed

An MS, Yoo JH, Kim KH, Bae KB, Choi CS, Hwang JW, Kim JH, Kim BM, Kang MS, MK O, Hong KH (2015) T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. World J Surg Oncol 13:64CrossRefPubMedPubMedCentral

Acheson AG, Brookes MJ, Spahn DR (2012) Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256(2):235–244CrossRefPubMed

Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1:CD005033

Ludwig H, Muldur E, Endler G, Hubl W (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 24(7):1886–1892CrossRefPubMedPubMedCentral

Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011–1023CrossRefPubMed

Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H (2015) Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr 127:907–919CrossRefPubMedPubMedCentral

10.

Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C (2006) Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55(10):1449–1460CrossRefPubMedPubMedCentral

11.

Borstlap W, Stellingwerf ME, Moolla Z, Musters GD, Buskens CJ, Tanis PJ, Bemelman WA (2015) Iron therapy for the treatment of preoperative anaemia in patients with colorectal carcinoma: a systematic review. Colorectal Dis 17:1044–1054CrossRefPubMed

12.

Beale AL, Penney MD, Allison MC (2005) The prevalence of iron deficiency among patients presenting with colorectal cancer. Color Dis 7(4):398–402CrossRef

13.

Richards T, Clevenger B, Keidan J, Collier T, Klein AA, Anker SD, Kelly JD (2015) PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial. Trials 16:254CrossRefPubMedPubMedCentral

14.

Borstlap WA, Buskens CJ, Tytgat KM, Tuynman JB, Consten EC, Tolboom RC, Heuff G, van Geloven AA, van Wagensveld BA, CAW CA, Gerhards MF, de Castro SM, Jansen J, van der Ven AW, van der Zaag E, Omloo JM, van Westreenen HL, Winter DC, Kennelly RP, Dijkgraaf MG, Tanis PJ, Bemelman WA (2015) Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients. BMC Surg 15:78CrossRefPubMedPubMedCentral

15.

NCCN (2014) Cancer- and chemotherapy-induced anemia. Version 3.2014. National Comprehensive Cancer Network Inc, Fort Washington

16.

Schrijvers D, De Samblanx H, Roila F, Group EGW (2010) Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol 21(Suppl 5):v244–v247CrossRefPubMed

17.

Calleja JL, Delgado S, del Val A, Hervas A, Larraona JL, Teran A, Cucala M, Mearin F, Colon Cancer Study G (2016) Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. Int J Color Dis 31(3):543–551CrossRef

18.

Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM (2016) The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg 264:41–46CrossRefPubMedPubMedCentral

19.

Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK (2011) Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 212(2):187–194CrossRefPubMed

20.

Zhen L, Zhe S, Zhenning W, Zhifeng M, Zhidong L, Xiaoxia L, Jianguang Y, Huimian X (2012) Iron-deficiency anemia: a predictor of diminished disease-free survival of T3N0M0 stage colon cancer. J Surg Oncol 105(4):371–375CrossRefPubMed

21.

Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of H, the American Society of Clinical Oncology Practice Guideline Update C (2010) American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116(20):4045–4059CrossRefPubMed

22.

Brownlie T, Utermohlen V, Hinton PS, Haas JD (2004) Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 79(3):437–443PubMed

23.

Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, Bischoff T, de Vevey M, Studer JP, Herzig L, Chapuis C, Tissot J, Pecoud A, Favrat B (2003) Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 326(7399):1124CrossRefPubMedPubMedCentral

24.

25.

Keeler BD, Simpson JA, Ng S, Tselepis C, Iqbal T, Brookes MJ, Acheson AG (2014) The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. Color Dis 16(10):794–800CrossRef

26.

Ilsley JN, Belinsky GS, Guda K, Zhang Q, Huang X, Blumberg JB, Milbury PE, Roberts LJ 2nd, Stevens RG, Rosenberg DW (2004) Dietary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer 49(2):162–169CrossRefPubMed

27.

Radulescu S, Brookes MJ, Salgueiro P, Ridgway RA, McGhee E, Anderson K, Ford SJ, Stones DH, Iqbal TH, Tselepis C, Sansom OJ (2012) Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. Cell Rep 2(2):270–282. https://doi.org/10.1016/j.celrep.2012.07.003 CrossRefPubMed

28.

Wilson MJ, van Haaren M, Harlaar JJ, Park HC, Bonjer HJ, Jeekel J, Zwaginga JJ, Schipperus M (2017) Long-term prognostic value of preoperative anemia in patients with colorectal cancer: a systematic review and meta-analysis. Surg Oncol 26(1):96–104CrossRefPubMed

Title: The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment
Authors: M. J. Wilson
J. W. T. Dekker
J. J. Harlaar
J. Jeekel
M. Schipperus
J. J. Zwaginga
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 11/2017
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-017-2898-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment

Abstract

Background

Objective

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2017

Treatment of transsphincteric fistula-in-ano with growth factors from autologous platelets: results of a phase II clinical trial

Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer

Should we offer ventral rectopexy to patients with recurrent external rectal prolapse?

Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer

The correlation between diverticulosis and redundant colon

A prospective non-randomized controlled, multicenter trial comparing Appendectomy and Conservative Treatment for Patients with Uncomplicated Acute Appendicitis (the ACTUAA study)